Logo

NCI Renews Funding Program for Cancer Detection

Sep 19, 2005

NEW YORK, Sept. 19 (GenomeWeb News) - The National Cancer Institute last week renewed a funding program called "Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis."

 

The program, first released in October 2002, seeks to fund exploratory research to evaluate new molecular or cellular characteristics of pre-malignant cells or tumors or to develop assays that will be useful for cancer detection, diagnosis, or prognosis. It is sponsored by the NCI's Cancer Diagnosis Program, the Cancer Therapy Evaluation Program, and the Cancer Biomarkers Research Group.

 

Funding will be available through the R21 award mechanism, which allows up to $275,000 in direct costs over two years. The total amount awarded and number of awards are not predetermined.

Breaking News
The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.